Medical Journals

Role of Spinal Voltage-dependent Calcium Channel Alpha 2 Delta-1 Subunit in the Expression of a Neuropathic Pain-like State in Mice.

Authors:
  • Narita Minoru
  • Nakajima Mayumi
  • Miyoshi Kan
  • Narita Michiko
  • Nagumo Yasuyuki
  • Miyatake Mayumi
  • Yajima Yoshinori
  • Yanagida Kiyomi
  • Yamazaki Mitsuaki
  • Suzuki Tsutomu

From: Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. narita@hoshi.ac.jp

Life sciences

  • Publish Date: May 2007
  • ISSN: 0024-3205
  • Volume: 80
  • Issue: 22
  • Pages: 2015-24
  • Medium: Print
  • Language: English
  • Citation (JAMA): Narita Minoru, Nakajima Mayumi, Miyoshi Kan, et al. Role of Spinal Voltage-dependent Calcium Channel Alpha 2 Delta-1 Subunit in the Expression of a Neuropathic Pain-like State in Mice.. Life Sci. May 2007;80:2015-24

Abstract

The present study was undertaken to investigate the role of spinal voltage-dependent calcium channel alpha(2)delta-1 subunit in the expression of a neuropathic pain-like state induced by partial sciatic nerve ligation in mice. In cultured spinal neurons, gabapentin (GBP), which displays the inhibitory effect of alpha(2)delta-1 subunit, suppressed the extracellular Ca(2+) influx induced by KCl, whereas it failed to inhibit the intracellular Ca(2+) release induced by inositol-1,4,5-triphosphate. Seven days after sciatic nerve ligation, the protein level of alpha(2)delta-1 subunit in the ipsilateral spinal cord was clearly increased compared to that observed in sham-operated mice. In addition, the mRNA level of alpha(2)delta-1 subunit was significantly increased in the dorsal root ganglion, but not in the spinal cord, of nerve-ligated mice. Under these conditions, a marked decrease in the latency of paw-withdrawal against a thermal stimulation and tactile stimulation, induced by sciatic nerve ligation was abolished by repeated intrathecal (i.t.) treatment with GBP. Additionally, the persistent reduction in the nociceptive threshold by i.t. treatment with GBP at the early stage of the neuropathic pain-like state was maintained for 7 days even after GBP withdrawal. It is of interest to note that a single i.t. post-injection of GBP showed a marked and transient inhibitory effect on the developed neuropathic pain-like state, whereas repeated i.t. post-treatment with GBP produced a persistent inhibitory effect during the treatment. In conclusion, we propose here that the neuropathic pain-like state with sciatic nerve ligation is associated with the increased level of the alpha(2)delta-1 subunit of Ca(2+) channels at the sensory nerve terminal in the spinal dorsal horn of mice. Furthermore, the present data provide evidence that the neuropathic pain may be effectively controlled by repeated treatment with GBP at the early stage.

Mesh Headings (Keywords): Amines, Analgesics, Animals, Calcium Channels, Cells, Cultured, Cyclohexanecarboxylic Acids, Disease Models, Animal, Gene Expression, Injections, Spinal, Male, Mice, Pain Measurement, Pain Threshold, Protein Subunits, RNA, Messenger, Sciatica, Up-Regulation, gamma-Aminobutyric Acid


Check for Full Text / PubMed Unique Identifier (PMID): 17442347


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.